The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

The widespread use of antibiotics has resulted in the emergence of drug-resistant
populations of microorganisms. Clearly, one can see the need to develop new, more …

In this study, we newly designed and synthesized a small library of ten structurally related C,
N‐cyclometalated ruthenium (II) complexes containing various pyridine‐functionalized NHC …

Abstract (E)-1-((((1H-benzo [d] imidazol-2-yl) methyl) imino) methyl) naphthalen-2-ol, ligand
was synthesized by condensation of (1H-benzo [d] imidazol-2-yl) methanamine, with 2 …

In antimalarial drug development research, overcoming drug resistance has been a major
challenge for researchers. Nowadays, several drugs like chloroquine, mefloquine …

In the face of the recent pandemic and emergence of infectious diseases of viral origin,
research on parasitic diseases such as malaria continues to remain critical and innovative …

With the aim of gaining new insight into the underlying apoptosis mechanisms and in vivo
efficacy of cyclometalated Ir (III) complexes as metalodrugs, six new cyclometalated Ir (III) …

A structure activity relationship (SAR) study of a library of 56 compounds (54 ruthenium and
2 osmium derivatives) based on the trithiolato-bridged dinuclear ruthenium (II)-arene …

The emergence of resistance to conventional antimalarial treatments remains a major cause
for concern. New drugs that target the distinct development stages of Plasmodium parasites …

Recent advances in the metal‐organic framework (MOF) have accelerated the discovery of
novel metal‐based anticancer, antibacterial and antimalarial compounds. This is …